This observation aligns with prior research, which has reported a marked reduction in IGF-1 levels in obese patients with Type 2 Diabetes Mellitus, in comparison to obese non-diabetic patients and lean control subjects. The gene discussed is IGF1; the disease is type 2 diabetes mellitus.